Ma et al. showed that when normal kidney cells (HK-2 and mTEC cells) were co-treated with cisplatin and TSA, the TSA-induced upregulation of bone morphogenetic protein 7 (BMP-7) reduced the nephrotoxicity of cisplatin, protecting the kidney cells from cisplatin-induced acute kidney injury (AKI) [156]. This evidence concerns the gene BMP7 and acute kidney injury.